eriodictyol has been researched along with mocetinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| 'T Hart, BA; Ip Via Ching, TR; Labadie, RP; Van Dijk, H | 1 |
| Andrade, GM; Carmo, MR; Fernandes, MY; Ferreira, Ede O; Fonteles, AA; Lima, FA; Lima, NM; Menezes, AP; Neves, KR | 1 |
2 other study(ies) available for eriodictyol and mocetinostat
| Article | Year |
|---|---|
How flavonoids inhibit the generation of luminol-dependent chemiluminescence by activated human neutrophils.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcimycin; Flavanones; Flavonoids; Flavonols; Hesperidin; Humans; Luminescent Measurements; Luminol; Luteolin; Neutrophils; Oxygen; Peroxidase; Pyridazines; Quercetin; Superoxides; Tetradecanoylphorbol Acetate; Xanthine Oxidase | 1990 |
Neuroinflammatory response to experimental stroke is inhibited by eriodictyol.
Topics: Animals; Astrocytes; Brain; Brain Ischemia; Cell Survival; Disease Models, Animal; Encephalitis; Exploratory Behavior; Flavanones; Locomotion; Male; Memory, Short-Term; Mice; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; Peroxidase; Stroke; Tumor Necrosis Factor-alpha | 2016 |